Skip to main content
. 2025 Jul 11;120:107464. doi: 10.1016/j.ultsonch.2025.107464

Table 3.

Estimated SA serum PK parameters applying NCA sparse data analysis using Phoenix® for inhaled and oral aspirin sample F6.

Parameter Cmax
(µg/mL)
Tmax
(h)
T1/2
(h)
AUC0-∞
(µg·h/mL)
Relative
bioavailability (%)
Oral 26.21 ± 4.90 0.5 4.12 121.36
Inh 46.05 ± 2.60 0.17 2.69 231.88 1.91